MLchartDataset catalogue

RPI.4610

Term · Oncology and biomedicine · MLC-T-ONC-007504

A substance being studied in the treatment of cancer. RPI.4610 is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called Angiozyme.

Table 1. Record
IdentifierMLC-T-ONC-007504
FieldOncology and biomedicine
ExpansionsAngiozyme
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-007504",
  "term": "RPI.4610",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. RPI.4610 is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called Angiozyme.",
  "expansions": [
    "Angiozyme"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rpi-4610/"
}

Record 14,584 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.